Subclinical intestinal inflammation in siblings of children with crohn's disease

Digestive Diseases and Sciences

Volumn 55, Issue 12, 2010, Pages 3502-3507

  Pham, Mimi ^a   Leach, Steven T ^b   Lemberg, Daniel A ^a   Day, Andrew S ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Calprotectin; Children; Crohn's disease; Inflammation

Indexed keywords

CALCIUM BINDING PROTEIN; CALGRANULIN; PROTEIN S100 A12; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMAN; MALE; MORBIDITY; NORMAL HUMAN; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING;

ADOLESCENT; ADULT; CHILD; CROHN DISEASE; FECES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTESTINES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PARENTS; RISK FACTORS; S100 PROTEINS; SIBLINGS; YOUNG ADULT;

EID: 78649334250     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1434-8     Document Type: Article

References (33)

1. J Langhorst S Elsenbruch T Mueller, et al. 2005 Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis Inflamm Bowel Dis 11 1085 1091 10.1097/01.MIB.0000187980. 08686.18 16306771
2. P Brandtzaeg G Haraldsen J Rugtveit 1997 Immunopathology of human inflammatory bowel disease Springer Sem Immunopathol 18 555 589 1:CAS:528:DyaK2sXjsV2iurw%3D 10.1007/BF00824058
3. P Krugliak D Hollander TY Ma, et al. 1989 Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine Gastroenterology 97 1164 1170 1:CAS:528:DyaL1MXmt1CktLg%3D 2792655
4. D Hollander 1992 The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease Scand J Gastroenterol 27 721 726 1:STN:280:DyaK3s%2FjtVCgtA%3D%3D 10.3109/00365529209011172 1411276
5. I Bjarnason A MacPherson D Hollander 1995 Intestinal permeability: an overview Gastroenterology 108 1566 1581 1:STN:280:DyaK2M3ks12qsQ%3D%3D 10.1016/0016-5085(95)90708-4 7729650
6. KD Katz D Hollander CM Vadheim, et al. 1989 Intestinal permeability in patients with Crohn's disease and their healthy relatives Gastroenterology 97 927 931 1:STN:280:DyaL1MznvVKluw%3D%3D 2506103
7. K Teahon P Smethurst AJ Levi IS Menzies I Bjarnason 1992 Intestinal permeability in patients with Crohn's disease and their first-degree relatives Gut 33 320 323 1:STN:280:DyaK383jsVamtA%3D%3D 10.1136/gut.33.3.320 1568650
8. M Peeters B Geypens D Claus, et al. 1997 Clustering of increased small intestinal permeability in families with Crohn's disease Gastroenterology 113 802 807 1:STN:280:DyaK2svjsVSrtw%3D%3D 10.1016/S0016-5085(97)70174-4 9287971
9. JD Soderholm G Olaison E Lindberg, et al. 1999 Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut 44 96 100 1:STN:280: DyaK1M%2FotFKlsQ%3D%3D 10.1136/gut.44.1.96 9862833
10. B Thjodleifsson G Sigthorsson N Cariglia, et al. 2003 Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 124 1728 1737 10.1016/S0016-5085(03)00383-4 12806605
11. J Roth M Goebeler C Sorg 2001 S100A8 and S100A9 in inflammatory diseases Lancet 357 1041 1:STN:280:DC%2BD3M3ivV2htA%3D%3D 10.1016/S0140-6736(05)71610-X 11293617
12. J Roth T Vogl C Sorg, et al. 2003 Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules Trends Immunol 24 155 158 1:CAS:528:DC%2BD3sXivFCksb4%3D 10.1016/S1471-4906(03)00062-0 12697438
13. A Poullis R Foster MA Mendall, et al. 2003 Emerging role of calprotectin in gastroenterology J Gastroenterol Hepatol 18 756 762 1:CAS:528: DC%2BD3sXmvFSht70%3D 10.1046/j.1440-1746.2003.03014.x 12795745
14. E Olafsdottir L Aksnes G Fluge A Berstad 2002 Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children Acta Paediatr 91 45 50 1:STN:280:DC%2BD387ltFajsw%3D%3D 10.1080/080352502753457932 11883817
15. JA Tibble G Sigthorsson S Bridger MK Fagerhol I Bjarnason 2000 Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease Gastroenterology 119 15 22 1:STN:280: DC%2BD3czkvFCjuw%3D%3D 10.1053/gast.2000.8523 10889150
16. JA Tibble G Sigthorsson R Foster, et al. 2002 Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease Gastroenterology 123 450 460 10.1053/gast.2002.34755 12145798
17. RB Canani G Terrin L Rapacciuolo, et al. 2008 Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease Dig Liver Dis 40 547 553 10.1016/j.dld.2008.01.017 18358796
18. M Frosch D Metze D Foell, et al. 2005 Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis Exp Dermatol 14 259 265 10.1111/j.0906-6705.2005.00271.x 15810883
19. D Foell T Kucharzik M Kraft, et al. 2003 Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease Gut 52 847 853 1:STN:280:DC%2BD3s3hvFSksA%3D%3D 10.1136/gut.52.6.847 12740341
20. T Vogl C Propper M Hartmann, et al. 1999 S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14 J Biol Chem 274 25291 25296 1:CAS:528:DyaK1MXmtVWitLk%3D 10.1074/jbc.274.36.25291 10464253
21. T Kaiser J Langhorst H Wittkowski, et al. 2007 Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome Gut 56 1706 1713 1:CAS:528:DC%2BD1cXmsFKlsg%3D%3D 10.1136/gut.2006.113431 17675327
22. NSH de Jong ST Leach AS Day 2006 Fecal S100A12: a novel noninvasive marker in children with Crohn's disease Inflamm Bowel Dis 12 566 572 10.1097/01.ibd.0000227626.72271.91 16804393
23. MA Sidler ST Leach AS Day 2008 Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children Inflamm Bowel Dis 14 359 366 10.1002/ibd.20336 18050298
24. Griffiths AM, Buller HB. Inflammatory bowel diseases. In: Walker WA, Hamilton JR, et al. eds. Pediatric Gastrointestinal Disease. Hamilton Ontario: BC Decker; 2000: 613-52, Chap. 41.
25. M Silverberg J Satsangi T Ahmad, et al. 2005 Toward an integral clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 Suppl A 5A 36A
26. JS Hyams GD Ferry FS Mandel, et al. 1991 Development and validation of a pediatric Crohn's disease activity index J Pediatr Gastroenterol Nutr 12 439 447 1:STN:280:DyaK3MzisV2qtA%3D%3D 1678008
27. DS Pardi WJ Sandborn 2005 Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers? Gut 54 321 322 1:STN:280:DC%2BD2M%2FotFGrug%3D%3D 10.1136/gut.2004.048850 15710974
28. MA Hofmann S Drury C Fu, et al. 1999 RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 889 901 1:CAS:528:DyaK1MXktlCltrc%3D 10.1016/S0092-8674(00) 80801-6 10399917
29. G Olaison R Sjodahl C Tagesson 1990 Abnormal intestinal permeability in Crohn's disease. A possible pathogenic factor Scand J Gastroenterol 25 321 328 1:STN:280:DyaK3c3ks1WnsA%3D%3D 10.3109/00365529009095493 2186473
30. D Hollander 1993 Permeability in Crohn's disease: altered barrier functions in healthy relatives? Gastroenterology 104 1848 1851 1:STN:280:DyaK3s3ntlajtQ%3D%3D 8500744
31. P Munkholm E Langholz D Hollander, et al. 1994 Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives Gut 35 68 72 1:STN:280:DyaK2c7ktVaitQ%3D%3D 10.1136/gut.35.1.68 8307453
32. D Ruttenberg GO Young JP Wright S Isaacs 1992 PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers Dig Dis Sci 37 705 708 1:STN:280:DyaK383isVOktg%3D%3D 10.1007/BF01296426 1563311
33. M Ainsworth J Eriksen JW Rasmussen OB Schaffalitzky de Muckadell 1989 Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives Scand J Gastroenterol 24 993 998 1:STN:280:DyaK3c%2FosVemsA%3D%3D 10.3109/00365528909089246 2512633